Apixaban is a Biopharmaceutics Classification System (BCS) class II anticoagulant whose clinical performance is limited by poor aqueous solubility and dissolution rate, leading to variable oral absorption. The present study aimed to develop and evaluate apixaban nanocrystals using the antisolvent precipitation techniqu...
{"name":"Ravi Teja P. D","email":"ravetezah@gmail.com","affiliat, {"name":"E Murali Nath","email":"ravetezah@gmail.com","affili, {"name":"Thota Bhavya Sree","email":"ravetezah@gmail.com","affili et al.· Future Journal of Pharmaceut...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.